关键数据
6.940今开
7.220最高
1.61K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.06%换手率
7.000昨收
6.940最低
11.26K成交额
亏损市盈率静
3.19市净率
0.00%股息率 TTM
-83.16%ROA
15.24052周最高
0.39量比
-28.94M净利润
2.78M总股本
-207.0822每股收益TTM
0.36Beta
-209.10%ROE
4.14052周最低
4.00%振幅
34.21%毛利率
20.06M总市值
-2.42回报/风险
5.25%风险率
操作建议
Lifeward Ltd当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名110/199位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价20.00。中期看,股价处于平稳状态。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Lifeward Ltd新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Lifeward Ltd简介
Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
公司代码LFWD
公司Lifeward Ltd
CEOGrant (Mark Stuart)
网址https://golifeward.com/
公司股东
常见问题
Lifeward Ltd(LFWD)的当前股价是多少?
Lifeward Ltd(LFWD)的当前股价是 7.12。
Lifeward Ltd股票的52周最高点是多少?
Lifeward Ltd股票的52周最高点是15.24。
Lifeward Ltd股票的52周最低点是多少?
Lifeward Ltd股票的52周最低点是4.14。
现在Lifeward Ltd(LFWD)的股票是买入、持有还是卖出?
根据分析师评级,Lifeward Ltd(LFWD)的总体评级为买入,目标价格为20.00。
Lifeward Ltd(LFWD)股票的每股收益(EPS TTM)是多少
Lifeward Ltd(LFWD)股票的每股收益(EPS TTM)是-205.91。